NDC 73042-201-01
DANYELZA 40 mg/10mL
Naxitamab · INJECTION
DANYELZA is a injection containing naxitamab at a strength of 40 mg/10mL. Manufactured by Y-mAbs Therapeutics, Inc..
Key Facts
- Brand Name
- DANYELZA
- Generic Name
- Naxitamab
- NDC Code (Package)
73042-201-01- NDC Code (Product)
73042-201- Manufacturer
- Y-mAbs Therapeutics, Inc.
- Strength
- 40 mg/10mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761171
- Drug Class
- Glycolipid Disialoganglioside-directed Antibody [EPC]
- Marketing Start
- 11/25/2020
Recall History
No Recall HistoryView Full Drug Page
DANYELZA — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.